Live Sessions
08:30 – 10:00 hrs | Concurrent Symposia S18-S20
Chairs: Serena Nik-Zainal
Room: A6+A7
S18.1 Somatic Mutation and Clonal Expansions in Human Tissues
Inigo Martincorena;
United Kingdom
S18.2 Somatic Genetic Rescue in Mendelian Haematopoietic Diseases
Patrick Revy
France
S18.3 Somatic Mutations and Regeneration in Chronic Liver Disease
Hao Zhu;
United States
Chairs: Sam Riedijk
Room: A8
S19.1 Array-based mutation testing, PRS, PGx, and return of results in a hospital setting: the GOALL project
Andre Uitterlinden;
The Netherlands
S19.2 Empirical Evidence in Preventive Genomics: MedSeq, BabySeq and Beyond
Carrie Blout;
United States
S19.3 The challenges facing clinical-research hybrid practices
Anneke Lucassen;
United Kingdom
Chairs: Matti Pirinen
Room: A3
S20.1 Combining omics data with GWAS results
Alexander Gusev;
United States
S20.2 A Bayesian Framework for Joint Fine-Mapping with Applications to Immune-Mediated Diseases
Jennifer Asimit;
United Kingdom
S20.3 Integrative Transcriptomic Analysis in Neurodegenerative Diseases
Towfique Raj;
United States
10:00 – 10:15 hrs | Break
10:15 – 11:45 hrs | Concurrent Sessions C26-C28 from submitted abstracts
Chairs: tba
Room: Hall B
C26.1 Electrical impedance detection based GenapSys sequencer enables diverse genomic applications
Saurabh Paliwal, A. Nabi, M. Fallahi, M.R. Barmi, M. Jouzi, S. Stern, X. Gomes, H. Nezamfar, E. LoPrete, B. Dong, P. Kenney, K.B. Parizi, H. Rategh, S. Sankar, H. Esfandyarpour;
Redwood City, United States
C26.2 Genome wide mapping of DNA damage lesions by Repair-Assisted DNA Damage (R.A.D.D) sequencing and optical mapping
Yael Michaeli, H. Sharim, N. Gilat, N. Gassman, Y. Ebenstein;
Tel Aviv, Israel
C26.3 Analysis of Mendelian phenotypes through mouse embryo viability screening
Pilar Cacheiro, S.A. Murray, V. Muñoz-Fuentes, H. Westerberg, M.E. Dickinson, A. Mallon, T.F. Meehan, D. Smedley, the International Mouse Phenotyping Consortium;
London, United Kingdom
C26.4 Patient-derived retinal organoids to model retinitis pigmentosa 1 (RP1)
Patricia Berber*, A. Milenkovic, C. Brandl, B.H.F. Weber;
Regensburg, Germany
C26.5 High-throughput sequencing and mapping technologies applied to 10 human genomes with chromothripsis-like rearrangements
Uira Melo, R. Schöpflin, D. Heller, J. Herztberg, H. Moeinzadeh, M. Holtgrewe, M. Klever, J. Jungnitsch, S. Türkmen, V. Beensen, G. Barbi, B. Prager, A. Latos-Bielenska, M. Bugge, I. Vogel, N. Tommerup, V. Kalscheuer, M. Spielmann, M. Vingron, S. Mundlos;
Berlin, Germany
C26.6 Next generation cytogenetics: genome-imaging improves structural variant detection for constitutional chromosomal aberrations
Kornelia Neveling, T. Mantere, E. Kater-Baats, R. van Beek, M. Oorsprong, S. Vermeulen, M. Pauper, D. Olde Weghuis, M. Stevens-Kroef, G. van der Zande, D. Smeets, A. Hoischen;
Nijmegen, Netherlands
Chairs: tba
Room: A6+A7
C27.1 NCBI ALFA: Providing Sequence Variation Resource from 1 Million dbGaP Subjects
Lon Phan, NCBI dbSNP, NCBI dbGaP;
Bethesda, United States
C27.2 Predicting the effects of structural variants in the human genome
Philip Kleinert*, M. Kircher;
Berlin, Germany
C27.3 RNA secondary structure mediated by Alu insertion as a novel disease-causing mechanism
Emmanuelle Masson, S. Maestri, D.N. Cooper, C. Férec, J.M. Chen;
Brest, France
C27.4 Increased mutation rates and genome variation at active spermatogonial regulatory sites
Vera B. Kaiser, L. Talmane, Y. Kumar, F. Semple, M. MacLennan, Deciphering Developmental Disorders Study, D.R. FitzPatrick, M.S. Taylor, C.A. Semple;
Edinburgh, United Kingdom
C27.5 Resolving complex structural variants in recurrent brain tumors
K. Okonechnikov, J. Hübner, O. Chapman, A. Chakraborty, M. Pagadal, R. Bumb, S. Chandran, K. Kraft, R. Hidalgo, S. Mundlos, R. Wechsler-Reya, N. Coufal, M. Levy, J. Crawford, K. Pajtler, D. Reid, A. Schmitt, H. Carter, F. Ay, J. Dixon, J. Mesirov, S.M. Pfister, M. Kool, Lukas Chavez;
San Diego, United States
C27.6 Genomics England Data Aggregation: A deep catalogue of human variation data from 78,683 whole genomes
Loukas Moutsianas, M. Wielscher, A. Stuckey, S. Hunt, D.J. Rhodes, C.A. Odhams, I.M. Armean, P. Short, P. Flicek, A. Need, M. Hurles, E. Birney, M. Caulfield, A. Rendon, The Genomics England Research Consortium;
London, United Kingdom
Chairs: tba
Room: A3
C28.1 Pathogenic variants in RLIM/RNF12 lead to syndromic X-linked intellectual disability and congenital, neurologic and behavior disorders
Suzanna G.M. Frints, A. Ozanturk, G. Rodriguez Criado, U. Grasshoff, M. Field, S. Manouvrier-Hanu, S. Hickey, K. Gripp, C. Bauer, C. Schroeder, A. Toutain, T. Mihalic Mosher, B.J. Kelly, P. White, A. Dufke, S. Moon, D.C. Koboldt, E. Gerkes, A. van Haeringen, C. Ruivenkamp, C. Mignot, B. Keren, A. Müller, S. Waldmüller, M. Blandfort, U. Kordaß, K. Gardner, A. Trimouille, K.E.P. van Roozendaal, S.A. Haas, L. Murray, E. Haan, R. Carroll, J. Liebelt, L. Hobson, M. De Rademaeker, H. Brunner, J. Glatz, K. Devriendt, J. Vermeesch, M. Raynaud, O. Riess, J. Gribnau, N. Katsanis, P. Bauer, J. Gecz, C. Golzio, C. Gontan, V. Kalscheuer;
Maastricht, Netherlands
C28.2 De-novo and Biallelic pathogenic variants in NARS1 cause neurodevelopmental delay due to dominant negative and partial loss of function effect
Emer O’Connor, A. Manole, S. Efthymiou*, M. Mendes, M. Jennings, D. Jenkins, M. Lopez, R. Maroofian, V. Salpietro, S. Antonarakis, J. Vincent, T. B. Haack, F. Distelmaier, R. Horvath, J. Gleeson, H. Becker, J. Mandel, D. Koolen, H. Houlden;
London, United Kingdom
C28.3 Biallelic loss-of-function variants in TBC1D2B cause a neurodevelopmental disorder with seizures and gingival overgrowth
Frederike L. Harms*, P. Parthasarathy, D. Zorndt, M. Alawi, S. Fuchs, B.J. Halliday, C. McKeown, H. Sampaio, N. Radhakrishnan, S.K. Radhakrishnan, R. Sachdev, S.P. Robertson, S. Nampoothiri, K. Kutsche;
Hamburg, Germany
C28.4 De novo pathogenic variants in CSNK2B cause a new intellectual disability-craniodigital syndrome distinguished from Poirier-Bienvenu neurodevelopmental syndrome
Maria Asif*, E. Kaygusuz, M. Shinawi, A. Nickelsen, J. Hochscherf, D. Lindenblatt, A.A. Noegel, S. Tinschert, K. Niefind, P. Fortugno, J. Jose, F. Brancati, P. Nürnberg, M.S. Hussain;
Cologne, Germany
C28.5 Biallelic and monoallelic variants in PLXNA1 cause a syndromic disorder with neurodevelopmental and oculo-cerebral anomalies
Gabriel C. Dworschak*, J. Punetha, J.C. Kalanithy, E. Mingardo, H.B. Erdem, Z.C. Akdemir, E. Karaca, T. Mitani, D. Marafi, J.M. Fatih, S.N. Jhangiani, J.V. Hunter, T. Dakal, B. Dhabhai, O. Dabbagh, H.S. Alsaif, F.S. Alkuraya, R. Maroofian, H. Houlden, S. Efthymiou, N. Dominik, V. Salpietro, T. Sultan, S. Haider, F. Bibi, H. Thiele, J. Hoefele, K.M. Riedhammer, M. Wagner, I. Guella, M. Demos, B. Keren, J. Buratti, P. Charles, C. Nava, E. Valkanas, L.B. Waddell, K.J. Jones, E.C. Oates, S.T. Cooper, D. MacArthur, R.E. Schnur, G.E. Hoganson, J.E. Burton, M. McEntagart, D. Pehlivan, J.E. Posey, J.R. Lupski, H. Reutter;
Bonn, Germany
C28.6 Mutations in Gemin5 cause developmental delay, motor dysfunction and cerebellar atrophy
Udai Pandey;
Pittsburgh, United States
11:45 – 12:30 hrs | Poster Viewing with Authors
12:30 – 12:45 hrs | Break
12:45 – 14:15 hrs | Concurrent Sessions C29-C31 from submitted abstracts
Chairs: tba
Room: A2
C29.1 Homozygous loss-of-function mutations in CCDC134 are responsible for a severe form of osteogenesis imperfecta
Johanne Dubail, P. Brunelle, G. Baujat, C. Huber, M. Doyard, C. Michot, P. Chavassieux, A. Khairouni, V. Topouchian, S. Monnot, E. Koumakis, V. Cormier-Daire;
Paris, France
C29.2 Hypomorphic variants in the replication complex member GINS3 result in a Meier Gorlin phenotype
Peter Kannu, E. Campos, H. Wurtele, K. Ahmed, R. Shaheen, M. McQuaid, K. Kernohan, K. Boycott, Z. Alhassnan, F. Alkuraya;
Toronto, Canada
C29.3 Homozygous EMILIN1 loss-of-function variants impair both elastin and collagen fiber formation and cause a novel entity with arterial tortuosity and osteopenia
Aude Beyens*, C. Adamo, E. Yilmaz Gulec, A. Gezdirici, P. Bonaldo, H. Bornaun, E. Brauchle, J. Brinckmann, W.P. Devine, B. Gangaram, T. Sasaki, K. Schenke-Layland, S. Symoens, A. Tam, G. Sengle, B. Callewaert;
Ghent, Belgium
C29.4 Transcriptional single-cell atlas of human limb malformation candidate genes
Cesar A. Prada-Medina*, G. Cova, J. Glaser, C. Dietrich, J. Henck, S. Mundlos, M.A. Mensah, M. Spielmann;
Berlin, Germany
C29.5 Tendon-to-bone attachment cells are bi-fated are regulated by shared enhancers KLF transcription factors
S. Kult, Tsviya Olender, M. Osterwalder, S. Krief, R. Blecher-Gonen, S. Ben-Moshe, L. Farack, H. Keren-Shaul, D. Leshkowitz, T.M. Salame, T.D. Capellini, S. Itzkovitz, I. Amit, A. Visel, E. Zelzer;
Rehovot, Israel
C29.6 Melorheostosis: two radiographic patterns are caused by somatic mosaicism for different genes with distinct pathophysiology underlying different clinical and histological presentation
Heeseog Kang, S. Jha, A. Ivovic, N. Fratzl-Zelman, Z. Deng, A. Mitra, W.A. Cabral, E.P. Hanson, E. Lange, E.W. Cowen, J. Katz, P. Roschger, K. Klaushofer, R.K. Dale, R.M. Siegel, T. Bhattacharyya, J.C. Marini;
Bethesda, United States
Chairs: tba
Room: A1
C30.1 Using reference-fixed principal components to improve polygenic risk score prediction
Olivier Naret*, J. Fellay;
Lausanne, Switzerland
C30.2 The Polygenic Score (PGS) Catalog: an open database to enable reproducibility and systematic evaluation
Samuel A. Lambert*, L. GIl, S. Jupp, M. Chapman, H. Parkinson, J. Danesh, J.A.L. MacArthur, M. Inouye;
Cambridge, United Kingdom
C30.3 Polygenic risk, breast cancer susceptibility genes, and breast cancer over the life course
Nina Mars*, E. Widén, T. Meretoja, S. Kerminen, M. Pirinen, P. Palta, A. Palotie, J. Kaprio, H. Joensuu, M. Daly, S. Ripatti;
Helsinki, Finland
C30.4 Genetic assessment of age-associated fracture risk
Carolina Medina-Gomez*, K. Trajanoska, C. Fan, O.A. Andreassen, M. Zillikens, A.M. Dale, A.G. Uitterlinden, T.M. Seibert, F. Rivadeneira;
Rotterdam, Netherlands
C30.5 Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic disease
Scott C. Ritchie*, Y. Liu, S.A. Lambert, B.G. Drew, A.C. Calkin, A.S. Butterworth, J. Danesh, M. Inouye;
Cambridge, United Kingdom
C30.6 Returning polygenic risk information for coronary artery disease and other traits to biobank participants
Minttu M. Marttila, T. Paajanen, H. Marjonen, A. Haukkala, H. Kääriäinen, K. Kristiansson, M. Perola;
Helsinki, Finland
Chairs: tba
Room: A4
C31.1 “It’s probably nothing, but⋯” Couples’ experiences of pregnancy following a uncertain prenatal genetic result
Stina Lou, K. Lomborg, C. Lewis, S. Riedijk, O. Petersen, I. Vogel;
Aarhus, Denmark
C31.2 Additional Genomic Findings: towards a feasible, effective model of care
E. Lynch, M. Martyn, L. Lee, A. Kanga-Parabia, R. Weerasuriya, R. Tytherleigh, Clara L. Gaff;
Parkville, Australia
C31.3 Analysis of laboratory exome sequencing reporting practices using a ‘virtual patient’
Danya F. Vears, M.G. Elferink, M. Kriek, P. Borry, K.L. van Gassen;
Leuven, Belgium
C31.4 Knowledge, attitudes and preparedness for polygenic risk testing in clinical practice: a cross-sectional survey of health professionals
Amelia K. Smit*, A.E. Cust, K. Dunlop, M. Young, B. Meiser, J. Tiller, T. Yanes;
Sydney, Australia
C31.5 Impact of the discussion of uncertainty on former counselees’ outcomes. An experimental vignettes study
Niki Medendorp, M. Hillen, C. Aalfs, A. Stiggelbout, E. Smets;
Amsterdam, Netherlands
C31.6 Primary Care Genomics: A roadmap for curriculum change and educational resource development
J. Hayward, I. Rafi, S. Simpson, E. Miller, A. Seller, Michelle Bishop;
Birmingham, United Kingdom
14:15 – 14:45 | Meet the speakers of Educational Sessions E10-E16
14:15 – 15:00 hrs | Break
15:00 – 15:45 hrs | Plenary Sessions PL4
Chairs: Alexandre Reymond, Joris Veltman
Room: Hall C
PL4.1 Mendel Lecture
Aviv Regev;
Cambridge, United States
15:45 – 16:30 hrs | Plenary Sessions PL5
Chairs: Alexandre Reymond, Joris Veltman
Room: Hall C
PL5.1 ESHG Award Lecture
Wendy Bickmore;
Edinburgh, United Kingdom
16:30 – 17:00 hrs | Plenary Sessions PL6
Chairs: Alexandre Reymond, Joris Veltman
Room: Hall C
EJHG-SN Citation Awards
ESHG Awards for Best Presentations by Young Investigators
European DNA Day Contest
Closing Address
On-demand Sessions
Always Available | Plenary Session PL0
Chairs: Alexandre Reymond, Joris Veltman
Room: Hall B
Always Available | Educational Session E02 – E16
Chair: Martin Kircher
Room: A3
E02.1 Reproducibility in Life Sciences
John Ioannidis;
Germany
E02.2 Classic misconceptions in high-throughput data analysis and how to learn from them
Bernhard Renard;
Germany
Chair: Vita Dolzan
Room: A1
E03.1 Pharmacogenetics – From Bench to Drug Label
Julija Stingl;
Germany
E03.2 Pharmacogenomic testing in clinical practice
Richard Turner;
United Kingdom
Chair: Johannes Zschocke
Room: A4
E04.1 Ehlers Danlos Syndromes and the Differential Diagnosis of Hypermobility
Franziska Malfait;
Belgium
E04.2 Vascular Presentation of the Ehlers Danlos Syndromes
Peter Byers;
United States
Chair: Martin Kircher
Room: A2
E05.1 Functional Characterization and Therapeutic Targeting of Gene Regulatory Elements
Nadav Ahituv;
United States
E05.2 Dissecting and Understanding Non-Coding Sequences
Alexander Stark;
Austria
Chair: Enza Maria Valente
Room: A4
E06.1 Microcephaly
Grazia M.S. Mancini;
The Netherlands
E06.2 Macrocephaly
Ghayda Mirzaa;
United States
Chairs: Carla Oliveira
Room: A8
E07.1 Editing the Mammalian Genome: Targets and Tools
Helen O’Niell;
United Kingdom
E07.2 Genome-Wide CRISPR-Cas9 Screening in Immune Cells
Pavel Tolar;
United Kingdom
Chairs: Ramona Moldovan
Room: A1
E08.1 What Was, What Is, What If – Trends and Predictions In Assessing Genetic Counseling
Robert Resta;
United States
E08.2 How to help society interact with genomic technology
Anna Middleton;
United Kingdom
Chairs: Aurora Pujol, Marni Falk
Room: A5
E09.1 Diagnostic Approach Update in Mitochondrial Disease
Marni Falk;
United States
E09.2 The Origin of mtDNA Mutations: Population Genetics and Disease
Patrick Chinnery ;
United Kingdom
Chairs: Joris Veltman
Room: A3
E10.1 Gene therapy in genetic disorders
Marina Cavazzana;
France
E10.2 Trial readiness, trial endpoints and stakeholder collaboration
Volker Stauber;
United Kingdom
Chairs: Zoltan Kutalik
Room: A5
E11.1 Heritability Estimation and Gene-Environment Interactions
Alexander Young;
United Kingdom
E11.2 Flexible Heritability Estimation from Summary Statistics
Doug Speed;
Denmark
Chairs: Christian Gilissen
Room: A3
E12.1 A Guide to Deep Learning in Healthcare
Mark DePristo;
United States
E12.2 A Guide to Deep Learning in Healthcare
Marcel Schulz;
Germany
Chairs: Edward Dove
Room: A1
E13.1 Mitochondrial replacement techniques: Exploring the biological consequences
Mary Herbert;
United Kingdom
E13.2 Should the UK’s Approach to MRT be Adopted in Other Countries?
César Palacios-González;
United Kingdom
Chair: Enza Maria Valente
Room: Hall B
E14.1 Recent Advances in the Identification and Characterization of Expanded Repeats
Paul J. Lockhart;
Australia
E14.2 Genetic Modifiers and Therapeutic Approaches in Repeat Expansion Disorders
Sarah J. Tabrizi;
United Kingdom
Chair: Conxi Lazaro
Room: A2
E15.1 Variant Interpretation in Hereditary Colorectal Cancer Syndromes: Lessons Learned from INSIGHT
Maurizio Genuardi;
Italy
E15.2 Variant interpretation in Hereditary Breast and Ovarian Cancer Syndrome Patients: Lessons Learned from ENIGMA, ClinGen and Other International Consortia
Fergus Couch;
United States
Chair: Cecilia Lindgren
Room: A1
E16.1 Optimising access to genetic services for consanguineous families: The UK experience
Naz Khan;
United Kingdom
E16.2 Consanguinity and endogamy in health and disease
Hilary Martin;
United Kingdom